Top Markets
Coin of the day
Epigenomics AG Epigenomics AG

Epigenomics AG

ECX
株式のランク #38933
Founded in 1998 and headquartered in Berlin, Germany, Epigenomics AG is a... Founded in 1998 and headquartered in Berlin, Germany, Epigenomics AG is a molecular diagnostics company dedicated to the early detection of cancer through liquid biopsy methods. Its primary offering, Epi proColon, is a blood-based assay specifically developed for the early identification of colorectal cancer, distributed across the United States, Europe, and China. The company's portfolio further encompasses a blood test for hepatocellular carcinoma and Epi BiSKit, a pre-analytical solution providing reagents essential for preparing bisulfite-converted DNA. Epigenomics' research and development initiatives are focused on pinpointing relevant biomarkers in human tissue and subsequently creating and securing patents for associated in vitro diagnostic blood tests.
株価
$0.83030862
最終同期: 2024-06-27
時価総額
$726.64K
変化(1日)
-1.35%
変化(1年)
0.00%
DE
取引 Epigenomics AG (ECX)

カテゴリー

Epigenomics AG(ECX)のP/S比率
2026 時点のP/S比率 TTM: 0
Epigenomics AG の最新の財務報告および株価によると、現在のP/S比率(TTM)は 0 です。2026 年末時点でのP/S比率は 0 でした。
Epigenomics AG の P/S 比率の履歴(2026 ~ 2026)
各年末時点のP/S比率
P/S比率 変化
提供された日付のデータは十分ではありません。
同業他社のP/S比率